Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cholinergic Receptor, Nicotinic, epsilon (Muscle) (CHRNE) Peptide

CHRNE Reactivity: Human, Mouse Host: Synthetic BP, WB
Catalog No. ABIN974964

Quick Overview for Cholinergic Receptor, Nicotinic, epsilon (Muscle) (CHRNE) Peptide (ABIN974964)

Target

CHRNE (Cholinergic Receptor, Nicotinic, epsilon (Muscle) (CHRNE))

Origin

Human, Mouse

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-CHRNE antibody (Catalog #: AVARP13023_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CHRNE (Cholinergic Receptor, Nicotinic, epsilon (Muscle) (CHRNE))

    Background

    After binding acetylcholine, the ACHR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.

    Alias Symbols: ACHRE, CMS1D, CMS1E, CMS2A, FCCMS, SCCMS

    Protein Interaction Partner: CHRNA1,CHRNA1

    Protein Size: 493

    Molecular Weight

    55 kDa

    Gene ID

    1145

    NCBI Accession

    NM_000080, NP_000071

    UniProt

    Q04844
You are here:
Chat with us!